Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$68.26 - $76.19 $8,464 - $9,447
-124 Reduced 3.19%
3,769 $287,000
Q1 2024

May 15, 2024

SELL
$67.36 - $77.59 $107,708 - $124,066
-1,599 Reduced 29.12%
3,893 $285,000
Q4 2023

Jan 30, 2024

BUY
$64.27 - $69.9 $835 - $908
13 Added 0.24%
5,492 $382,000
Q3 2023

Oct 23, 2023

BUY
$61.9 - $72.77 $2,228 - $2,619
36 Added 0.66%
5,479 $366,000
Q2 2023

Jul 24, 2023

BUY
$53.34 - $63.11 $6,827 - $8,078
128 Added 2.41%
5,443 $343,000
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $58,703 - $64,729
1,137 Added 27.21%
5,315 $302,000
Q4 2022

Feb 10, 2023

BUY
$51.15 - $57.45 $255 - $287
5 Added 0.12%
4,178 $216,000
Q3 2022

Nov 09, 2022

BUY
$49.9 - $57.32 $208,232 - $239,196
4,173 New
4,173 $218,000
Q2 2022

Aug 16, 2022

SELL
$49.62 - $58.13 $202,995 - $237,809
-4,091 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$48.27 - $65.25 $26,258 - $35,496
-544 Reduced 11.74%
4,091 $228,000
Q4 2021

Feb 15, 2022

SELL
$59.5 - $67.25 $18,326 - $20,713
-308 Reduced 6.23%
4,635 $303,000
Q3 2021

Nov 09, 2021

BUY
$60.19 - $75.29 $42,494 - $53,154
706 Added 16.66%
4,943 $322,000
Q2 2021

Aug 13, 2021

BUY
$62.12 - $74.2 $7,081 - $8,458
114 Added 2.76%
4,237 $312,000
Q1 2021

May 11, 2021

BUY
$57.98 - $73.08 $9,624 - $12,131
166 Added 4.2%
4,123 $253,000
Q4 2020

Feb 10, 2021

BUY
$62.61 - $71.29 $31,805 - $36,215
508 Added 14.73%
3,957 $282,000
Q3 2020

Nov 10, 2020

BUY
$51.39 - $72.41 $177,244 - $249,742
3,449 New
3,449 $240,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.